📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
SMS PHARMACEUTICALS LTDSMSPHARMAPharmaceuticals
Open
410
High
419.9
Low
401.1
Close
405.2
Volume
379792
Exchange
nse
Time
12-Mar-2026

Outlook

Score:

4.25

Rating:

FAIR

Candlestick Pattern

CandlepatternofSmsPharmaceuticalsis
Short Body
EstimatedStoplossofSmsPharmaceuticalsis
419.9
SmsPharmaceuticalshasa
Bearishℹ
pattern.
Formationof
Short Body
candlepatternindicatesthetrenddirectionofSmsPharmaceuticalsis
Unpredictableℹ
.

Trend

SmsPharmaceuticalsisin
Sideways trendℹ
.
PriceofSmsPharmaceuticalsis
Upℹ
by

15.16

%.
Target
Buy@

274.69

Sell@

401.63

Current@

405.2

Volume

ThetradevolumesofSmsPharmaceuticalshavebeen
Underperformingℹ
ThoughthevolumetrendforSmsPharmaceuticalsappears
Bullishℹ
theparticipantsseemtobe
Weak Buyersℹ
ThetradevolumeofSmsPharmaceuticalsis

Down

by

5.75

%

Valuation

ThecurrentmarketpriceofSmsPharmaceuticalsis
Undervaluedℹ

Financials

Balance
Withtotalliablitiesandshareholderequityworth1152crandtotalassetsworth1152cr,thebalancesheetofSmsPharmaceuticalsis:
Balancedℹ
.
Cashflow
SmsPharmaceuticalshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 5cr

.Itis
Downℹ
by

82.14

%.
32.27% i.e. ₹ 81cr earned in operatingℹ
49% i.e. ₹ 123cr spent in investingℹ
18.73% i.e. ₹ 47cr earned in financingℹ
0% in otherℹ
SmsPharmaceuticalshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 28cr

.Itis
Upℹ
by

171.79

%.
37.88% i.e. ₹ 50cr earned in operatingℹ
39.39% i.e. ₹ 52cr spent in investingℹ
22.73% i.e. ₹ 30cr earned in financingℹ
0% in otherℹ
Income
TheincomeofSmsPharmaceuticalsis

₹ 243cr

and

Profit

is:

₹ 25cr

SmsPharmaceuticalsProfitisupby:

38.89

%andIncomeisUpby:

23.98

%
TheincomeofSmsPharmaceuticalsis

₹ 196cr

and

Profit

is:

₹ 18cr

SmsPharmaceuticalsProfitisdownby:

10

%andIncomeisDownby:

21.29

%
TheincomeofSmsPharmaceuticalsis

₹ 249cr

and

Profit

is:

₹ 20cr

SmsPharmaceuticalsProfitisupby:

17.65

%andIncomeisUpby:

42.29

%
By using this site you agree to the use of cookies to deliver a better site experience.